您的位置: 首页 > 农业专利 > 详情页

APPLICATION À DES HUMAINS DE LYMPHOCYTES T COMPRENANT UN RÉCEPTEUR ANTIGÉNIQUE CHIMÉRIQUE (CAR)
专利权人:
THE UNIVERSITY OF TEXAS SYSTEM;BOARD OF REGENTS
发明人:
COOPER, LAURENCE, J.N.,WANG-JOHANNING, FENG,TORIKAI, HOROKI,HULS, HELEN,HURTON, LENKA,KRISHNAMURTHY, JANANI,OLIVARES, SIMON,ZHANG, LING
申请号:
EP14798046
公开号:
EP2997134A4
申请日:
2014.05.14
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
The present invention concerns methods and compositions for immunotherapy employing a modified T cell comprising a chimeric antigen receptor (CAR). In particular aspects, CAR-expressing T-cells are producing using electroporation in conjunction with a transposon-based integration system to produce a population of CAR-expressing cells that require minimal ex vivo expansion or that can be directly administered to patients for disease (e.g., cancer) treatment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充